Download Leukaemia Section t(10;11)(p12;q23) KMT2A/NEBL Atlas of Genetics and Cytogenetics in Oncology and Haematology

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Cre-Lox recombination wikipedia , lookup

Protein adsorption wikipedia , lookup

Histone acetylation and deacetylation wikipedia , lookup

Magnesium transporter wikipedia , lookup

Genome evolution wikipedia , lookup

Western blot wikipedia , lookup

Non-coding DNA wikipedia , lookup

Protein moonlighting wikipedia , lookup

Transcriptional regulation wikipedia , lookup

List of types of proteins wikipedia , lookup

Gene expression profiling wikipedia , lookup

Endogenous retrovirus wikipedia , lookup

Promoter (genetics) wikipedia , lookup

Gene wikipedia , lookup

Gene nomenclature wikipedia , lookup

Community fingerprinting wikipedia , lookup

Point mutation wikipedia , lookup

Gene regulatory network wikipedia , lookup

Vectors in gene therapy wikipedia , lookup

Molecular evolution wikipedia , lookup

Gene expression wikipedia , lookup

Silencer (genetics) wikipedia , lookup

RNA-Seq wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Transcript
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
INIST-CNRS
OPEN ACCESS JOURNAL
Leukaemia Section
Short Communication
t(10;11)(p12;q23) KMT2A/NEBL
Claus Meyer, Mariana Emerenciano, Maria S Pombo-de-Oliveira, Rolf Marschalek
Institute of Pharmaceutical Biology/ZAFES/Diagnostic Center of Acute Leukemia (DCAL), GoetheUniversity of Frankfurt, Max-von-Laue Str. 9, Frankfurt/Main, Germany (CM, RM), HematologyOncology Pediatric Program, CPq Instiuto Nacional de Cancer, Rio de Janeiro, Brazil (ME),
Hematology-Oncology Pediatric Program, CPq Instiuto Nacional de Cancer, Rio de Janeiro, Brazil
(MSPdO)
Published in Atlas Database: September 2014
Online updated version : http://AtlasGeneticsOncology.org/Anomalies/t1011p12q23ID1702.html
DOI: 10.4267/2042/56442
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence.
© 2015 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Abstract
Genes involved and
proteins
Review on t(10;11)(p12;q23) KMT2A/NEBL, with
data on clinics, and the genes implicated.
MLL/KMT2A
Clinics and pathology
Location
11q23
DNA/RNA
The Mixed-Lineage Leukemia gene consists of 37
exons, encoding a 3969 amino-acid nuclear protein
with a molecular weight of nearly 431 kDa.
Protein
431 kDa; contains two DNA binding motifs (a AT
hook and Zinc fingers), and a DNA methyl
transferase motif; wide expression; nuclear
localisation; transcriptional regulatory factor.
Disease
Infant acute myeloid leukemia (AML)
Phenotype/cell stem origin
AML-M5.
Epidemiology
Poorly defined, only one case described to date, a
11 month-old boy (Coser et al., 2010).
Prognosis
This infant was treated according to AML-BFM98
backbone adapted protocol and died 1 month later
while in the aplastic phase of treatment (Coser et
al., 2010).
NEBL
Location
10p12
Note
Nebulette, non-muscle isoform.
There exists also a sacomeric isoform of the NEBL
gene. Nebulette is the second member of the
nebulin family fused to MLL.
Cytogenetics
Probes
MLL dual color break apart rearrangement probe.
Atlas Genet Cytogenet Oncol Haematol. 2015; 19(4)
308
t(10;11)(p12;q23) KMT2A/NEBL
Meyer C, et al.
The probe was hybridized to interphase nuclei and displayed one split hybridization (arrow) signal that indicates translocation
with an unknown partner gene (Coser et al., 2010).
A. Left: Long-distance inverse polymerase chain reaction (LDI-PCR) analysis of both derivatives using genomic DNA. Lane M,
size marker; lane 1, LDI-PCR analysis of der(11) showing the wild-type (wt) band and the der(11) band (asterisk); lane 2, LDIPCR analysis of der(10) showing the wt band and the der(10) band (asterisk). Right: Genomic breakpoint sequence alignment of
both derivatives (MLL/NEBL and NEBL/MLL) with respective wt sequences (Coser et al., 2010). B. The genetic fusion of MLL
and NEBL in this AML patient occurred within the non-muscle form of the NEBL gene (intron 3) and within the known breakpoint
cluster region of MLL (intron 9). The gene structures are indicated and the recombination site is indicated by a dashed line
(Emerenciano et al., 2013). C. RT-PCR analyses of MLL-NEBL and NEBL-MLL fusion transcripts (Emerenciano et al., 2013).
Atlas Genet Cytogenet Oncol Haematol. 2015; 19(4)
309
t(10;11)(p12;q23) KMT2A/NEBL
Meyer C, et al.
Size and location of functional domains of the MLL wt, NEBL wt, and of the MLL-NEBL fusion protein. AT, AT hook, SNL,
subnuclear localization; MT, methyltransferase; BD, binding domain; TAD, transcriptional activation domain; PHD, plant homeo
domain; SET, Su(var)3e9; Enhancer-of-zeste, Trithorax; NEBU, nebulette units; SH3, SRC homology 3. (Coser et al., 2010).
the AT-hooks and the DNA methyltransferase
domain (DNMT) which is fused two nebulin
modules, the truncated serine-rich linker region and
the SH3 domain of the NEBL protein.
DNA/RNA
The Nebulette non-muscle isoform consists of 7
exons, encoding a 270 amino-acid protein with a
molecular weight of 31,2 kDa.
Protein
270 aa, 31,2 kDa.
To be noted
Note
Two other studies suggest that the reciprocal fusion
gene NEBL-MLL might be of biological
importance (Emerenciano et al., 2013; Wächter et
al., 2014).
Result of the chromosomal
anomaly
Hybrid gene
Note
Fusion gene MLL-NEBL and NEBL-MLL was
detected by LDI-PCR (Coser et al., 2010).
Description
In the described patient MLL exons 1-9 are fused to
NEBL (non-muscle isoform) exons 4-6 due to
translocation between MLL intron 9 and NEBL
(non-muscle isoform) intron 3. NEBL (non-muscle
isoform) exons 1-3 are fused to MLL exons 10-37
due to translocation between NEBL (non-muscle
isoform) intron 3 and MLL intron 10.
Detection
Detection method RT-PCR.
References
Cóser VM, Meyer C, Basegio R, Menezes J, Marschalek
R, Pombo-de-Oliveira MS. Nebulette is the second
member of the nebulin family fused to the MLL gene in
infant leukemia. Cancer Genet Cytogenet. 2010 Apr
15;198(2):151-4
Emerenciano M, Kowarz E, Karl K, de Almeida Lopes B,
Scholz B, Bracharz S, Meyer C, Pombo-de-Oliveira MS,
Marschalek R. Functional analysis of the two reciprocal
fusion genes MLL-NEBL and NEBL-MLL reveal their
oncogenic potential. Cancer Lett. 2013 May 10;332(1):30-4
Wächter K, Kowarz E, Marschalek R. Functional
characterisation of different MLL fusion proteins by using
inducible Sleeping Beauty vectors. Cancer Lett. 2014 Oct
1;352(2):196-202
Fusion protein
This article should be referenced as such:
Description
The 1582 amino acid big fusion protein retains a
major portion of MLL, including those domains
known to be essential for leukemic transformation:
Atlas Genet Cytogenet Oncol Haematol. 2015; 19(4)
Meyer C, Emerenciano M, Pombo-de-Oliveira MS,
Marschalek R. t(10;11)(p12;q23) KMT2A/NEBL. Atlas
Genet Cytogenet Oncol Haematol. 2015; 19(4):308 -310.
310
Related documents
Leukaemia Section t(10;11)(p11.2;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(10;11)(p11.2;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;11)(q28;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;11)(q28;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;11)(p21;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;11)(p21;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section DAB2IP (DAB2 interacting protein) Atlas of Genetics and Cytogenetics
Gene Section DAB2IP (DAB2 interacting protein) Atlas of Genetics and Cytogenetics
Leukaemia Section t(9;11)(q34;q23) AF9q34/MLL Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(9;11)(q34;q23) AF9q34/MLL Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;17)(q23;q12-21) MLL/LASP1 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;17)(q23;q12-21) MLL/LASP1 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(2;11)(q11;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(2;11)(q11;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;20)(q23;q11) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;20)(q23;q11) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section AF4p12 (ALL1 fused gene from chromosome 4p12)
Gene Section AF4p12 (ALL1 fused gene from chromosome 4p12)
Gene Section ABI1 (Abl-Interactor 1) Atlas of Genetics and Cytogenetics
Gene Section ABI1 (Abl-Interactor 1) Atlas of Genetics and Cytogenetics
Leukaemia Section t(11;19)(q23;p13.3) MLL/ACER1 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;19)(q23;p13.3) MLL/ACER1 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section SEPT6 (septin 6) Atlas of Genetics and Cytogenetics
Gene Section SEPT6 (septin 6) Atlas of Genetics and Cytogenetics
Leukaemia Section del(11)(q23q23) MLL/ARHGEF12 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section del(11)(q23q23) MLL/ARHGEF12 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;11)(q13;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;11)(q13;q23) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section inv(11)(q13q23)  Atlas of Genetics and Cytogenetics
Leukaemia Section inv(11)(q13q23) Atlas of Genetics and Cytogenetics
Leukaemia Section t(11;14)(q23;q32) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(11;14)(q23;q32) Atlas of Genetics and Cytogenetics in Oncology and Haematology